Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNNN.L Regulatory News (NNN)

  • There is currently no data for NNN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of CEO and other board changes

1 Sep 2021 07:00

RNS Number : 3054K
Nanosynth Group PLC
01 September 2021
 

1 September 2021

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR') which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside is now considered to be in the public domain.

 

nanosynth group plc

("nanosynth" the "Company" or the "Group")

Appointment of CEO and other board changes

The Board of nanosynth is pleased to announce the appointment of Mr. Mark Duffin as Chief Executive Officer of nanosynth, effective immediately.

 

Mr. Duffin is a qualified engineer with a multi-disciplinary background established over 20 years, including as CEO and board member of various companies in the technology, business services, industrial, manufacturing and consultancy sectors. His experience includes start-up companies, mergers and acquisitions and turnaround propositions.

Mr. Duffin is currently CEO and founder of Angel Share Capital Ltd and prior to that, was CEO of ServicePower Technologies plc (previously AIM listed) where he was responsible for executing a turnaround strategy for the company, resulting in a profit for the first time in fourteen years. Mr. Duffin holds an MBA and a BEng Hons.

 

With this appointment, and as previously envisaged, Antony Legge will revert to his previous role of non-executive Chairman of the Company. Dr Cave's move from a non-executive director to an executive director, taking the role of the Group's Chief Scientific Officer, remains subject to contract and a further announcement will be made once finalised.

 

 

 

Antony Legge, Chairman of nanosynth, said:

"I am delighted that a CEO of Mark's calibre has agreed to join the Company. His track record in creating shareholder value brings confidence that, together, we can continue to build nanosynth into a major player in the nanotech space."

 

Mark Duffin, Chief Executive, said:

"I am excited to be joining the Board as CEO of nanosynth and am looking forward to working with Antony and the wider team as we work towards growing the Company for the benefit of our stakeholders."

As part of his remuneration package Mr. Duffin will be granted share options over 5% of the Company's current share capital in accordance with the Company's EMI Share Scheme approved by shareholders at the Company's recent Annual General Meeting.

These options vest on the third anniversary from grant and are exercisable up until the 7th anniversary of grant.

The options are exercisable in various tranches at prices varying from 1.00p to 4.00p and are subject to various additional conditions including the requirement for the Company's 20 day volume weighted average share price to exceed the exercise price within certain timeframes. Further detail on the share options is set out below:

% of Issued Share Capital

Number of Options

Exercise Price per Option

Additional

Vesting Conditions

Exercise Conditions

Expiry Date

0.50%

10,395,360

1.00p

None

None

7 years from today

1.00%

20,790,720

1.25p

The 20 VWAP for the share price exceeding the Exercise Price at any time prior to 30 June 2022

The option cannot be exercise in the 6 months following vesting

7 years from today

2.50%

51,976,800

2.50p

The 20 VWAP for the share price exceeding the Exercise Price at any time prior to 30 June 2023

The option cannot be exercise in the 6 months following vesting

7 years from today

1.00%

20,790,720

4.00p

The 20 VWAP for the share price exceeding the Exercise Price at any time prior to 31 December 2023

The option cannot be exercise in the 6 months following vesting

7 years from today

 

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Mark Duffin, aged 54:

 Current directorships and/or partnerships:

Former directorships and/or partnerships (within the last five years):

 

Angel Share Capital Ltd

Angel Share Data Limited

 

Clipeus Ltd

Sounding Board Ideas Ltd

V-Tech Renewables Ltd

Digital Breadcrumbs Ltd

Verde Tech Group Limited

Prime Advantage Investors Ltd

Prime Advantage Ltd

Upwind Shipping Holdings Ltd

Upwinds Shipping Holdings Ltd

 

There are no further disclosures required under Schedule 2(g) of the AIM Rules for Companies.

 

- ENDS -

 

ENQUIRIES:

Remote Monitored Systems plc

+44 77 6355 5919

Antony Legge (Chairman)

 

 

 

SP Angel Corporate Finance LLP

+44 20 3470 0470

Nominated Adviser and Joint Broker

 

Stuart Gledhill

 

Caroline Rowe

 

Peterhouse Capital Limited

+44 20 7469 0930

Joint Broker

 

Lucy Williams

 

 

 

IFC Advisory Ltd

+44 20 3934 6630

Graham Herring

 

Zach Cohen

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUASRRAAUWOUR
Date   Source Headline
17th Nov 20237:00 amRNSCancellation - Nanosynth Group PLC
14th Nov 20234:10 pmRNSCompany Insolvency
29th Sep 20237:00 amRNSAccounts Update
30th Aug 20233:30 pmRNSAppointment of Joint Broker
30th Aug 20237:00 amRNSResignation of Finance Director
28th Jul 20233:53 pmRNSResignation of Chief Executive Officer
26th Jun 202311:24 amRNSAccounts Update
14th Jun 20233:27 pmRNSNotice re. General Meeting
24th May 20232:27 pmRNSNotice of General Meeting
16th May 202312:28 pmRNSProposal to Appoint Liquidators
16th May 202312:03 pmRNSSuspension - Nanosynth Group plc
28th Apr 20237:00 amRNSHolding(s) in Company
6th Apr 20233:05 pmRNSFinancial Position
31st Jan 20237:00 amRNSTotal Voting Rights
26th Jan 20233:42 pmRNSDirectorate Change
20th Jan 202310:48 amRNSHolding(s) in Company
17th Jan 20237:00 amRNSCorporate and Commercial Update
10th Jan 20237:00 amRNSPlacing and Subscription to raise £0.4 million
4th Jan 20232:56 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSHalf-year Report
6th Sep 20224:47 pmRNSHolding(s) in Company
1st Sep 20227:00 amRNSTotal Voting Rights
31st Aug 20224:41 pmRNSSecond Price Monitoring Extn
31st Aug 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20222:05 pmRNSSecond Price Monitoring Extn
31st Aug 20222:00 pmRNSPrice Monitoring Extension
31st Aug 202211:05 amRNSSecond Price Monitoring Extn
31st Aug 202211:00 amRNSPrice Monitoring Extension
31st Aug 20229:05 amRNSSecond Price Monitoring Extn
31st Aug 20229:00 amRNSPrice Monitoring Extension
31st Aug 20227:00 amRNSSuccessful Trial Results
30th Aug 20227:00 amRNSJoint Development Agreement in Cosmetics Market
26th Aug 20227:00 amRNSLanstead Subscription and Sharing Agreement
1st Aug 20222:05 pmRNSSecond Price Monitoring Extn
1st Aug 20222:00 pmRNSPrice Monitoring Extension
1st Aug 20221:08 pmRNSPDMR Dealings
26th Jul 20222:41 pmRNSResult of AGM
12th Jul 202211:06 amRNSSecond Price Monitoring Extn
12th Jul 202211:00 amRNSPrice Monitoring Extension
12th Jul 20229:05 amRNSSecond Price Monitoring Extn
12th Jul 20229:00 amRNSPrice Monitoring Extension
11th Jul 20224:40 pmRNSSecond Price Monitoring Extn
11th Jul 20224:36 pmRNSPrice Monitoring Extension
11th Jul 20222:06 pmRNSSecond Price Monitoring Extn
11th Jul 20222:00 pmRNSPrice Monitoring Extension
11th Jul 202211:05 amRNSSecond Price Monitoring Extn
11th Jul 202211:00 amRNSPrice Monitoring Extension
11th Jul 202210:30 amRNSDirector/PDMR dealings
6th Jul 20229:00 amRNSPrice Monitoring Extension
5th Jul 20222:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.